Ardena

Ardena is a leading CDMO providing early stage drug development and manufacturing for small-to-mid sized biopharma. Its multi-service platform offers a ‘Make, Analyse, File’ model, whereby services span from drug substance / product manufacturing and bioanalytical services through to regulatory dossier development. The Company’s reputation for high science, quality and flexibility has drawn a client base of over 300 customers across Europe, the US, Japan and Korea. Ardena is headquartered in Belgium, operating five other sites across the Netherlands, Sweden and Latvia.

www.ardena.com
Company
Ardena
Subsector
all, PharmaBio, Current
Investment date
December 2019
Deal status
Current
Our portfolio